Hyloris Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	140	151	310	276	375	220
Market Cap Growth	9.61%	-51.12%	12.35%	-26.54%	70.71%	-
Enterprise Value	125	130	277	230	337	168
Last Close Price	5.40	5.61	11.06	11.89	-	-
PS Ratio	19.35	18.76	94.97	130.24	144.35	1402.34
PB Ratio	5.67	5.70	9.14	5.77	9.30	4.16
P/TBV Ratio	6.57	6.03	10.13	5.97	9.67	4.26
EV/Sales Ratio	17.13	16.09	84.88	108.83	129.77	1068.71
Debt / Equity Ratio	0.06	0.06	0.05	0.02	0.18	0.14
Net Debt / Equity Ratio	-0.60	-0.69	-0.75	-0.80	-0.87	-0.95
Net Debt / EBITDA Ratio	3.01	3.59	1.86	3.77	4.06	11.13
Net Debt / FCF Ratio	2.53	3.22	2.22	3.28	3.68	12.25
Asset Turnover	0.21	0.22	0.07	0.04	0.05	0.01
Quick Ratio	3.76	4.12	5.14	8.32	3.53	30.33
Current Ratio	3.82	4.15	5.22	8.63	3.60	31.24
Return on Equity (ROE)	-20.18%	-17.81%	-33.08%	-23.35%	-21.62%	-29.24%
Return on Assets (ROA)	-9.03%	-8.94%	-18.27%	-11.58%	-9.73%	-8.44%
Return on Capital Employed (ROCE)	-19.40%	-18.60%	-38.70%	-20.90%	-21.30%	-7.60%
Earnings Yield	-3.92%	-3.46%	-4.31%	-3.83%	-2.59%	-2.91%
FCF Yield	-4.21%	-3.79%	-3.67%	-4.22%	-2.54%	-1.86%
Buyback Yield / Dilution	4.61%	-	-2.95%	-5.29%	-18.40%	-51.63%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.